#ESMO17 roundup: Idera shares spike on early TLR9 combo data; Erytech touts pancreatic cancer PhIIb data
MADRID — Shares of Idera $IDRA shot up 20% in pre-market trading on Monday as investors caught up with an encouraging look at early …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
